Increased chymase expression or activity has been observed in diabetic nephropathy [20, 21], hypertensive nephropathy [22], and kidney damage in endotoxemia [23], suggesting a central role of chymase in many forms of kidney diseases. Here, CMA1 is linked to serum lipopolysaccharide activity.